Mint: Transcript of interview with Ranbaxy’s Singh

The legal motion filed by the US federal authorities demanding Ranbaxy to handover confidential documents sent shares of the pharma group down 10% on Tuesday and it put a number of question marks on the future of the deal with the Japanese Daiichi Sankyo. However, on Wednesday Ranbaxy’s CEO Malvinder Singh managed to rescue his company as he personally reassured investors ahead of the market opening. A move which helped Ranbaxy recover most of its losses.

Today, Daiichi came out with a statement backing their “binding and final” agreement to takeover the company owned by the Singh family.